- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01057966
Bioavailability of Nutrients Contained in Softgel Capsules vs Tablets
January 31, 2012 updated by: Alcon Research
This study is a comparison of the bioavailability of nutrients contained in softgel capsules vs tablets.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Contact Alcon Call Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 to 35
- Body Mass Index (BMI) 21-27 kg/m2
- Must be able to give written informed consent
- Subjects must be willing to comply with all study requirements.
- Subjects must understand, sign and be given a copy of the written Informed Consent form.
Exclusion Criteria:
- Subjects for whom both eyes do not meet all inclusion criteria and either eye meets exclusion criteria
- Subjects who are pregnant, lactating or planning to be pregnant during the course of the study
- Subjects with known sensitivity to planned study concomitant medications
- Subjects participating in any other ophthalmic drug or device clinical trial within 30 days of this clinical investigation.
- Use of ocular drugs, other than study medications, during the study and within 14 days prior to study entry or any other ocular medication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ICAPS AREDS Softgel Capsule - Full Strength
ICAPS Eye Vitamin and Mineral Supplement - Softgel
|
Single full strength dose capsule taken one time
|
Experimental: ICAPS AREDS Softgel Capsule - Half Strength
ICAPS Eye Vitamin and Mineral Supplement - Softgel (half -strength)
|
Single half strength dose capsule taken one time
|
Experimental: ICAPS AREDS coated tablets - Full Strength
ICAPS Eye Vitamin and Mineral Supplement - Coated Tablets
|
Single, full strength dose tablet taken one time
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Bioavailability of nutrients
Time Frame: 1 week for each treatment cross-over period
|
1 week for each treatment cross-over period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
January 27, 2010
First Submitted That Met QC Criteria
January 27, 2010
First Posted (Estimate)
January 28, 2010
Study Record Updates
Last Update Posted (Estimate)
February 2, 2012
Last Update Submitted That Met QC Criteria
January 31, 2012
Last Verified
January 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMA-09-32
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vision
-
Ocuphire Pharma, Inc.Ophthalmic Consultants of Long IslandCompletedDecrease in Night Vision | Disturbance; Vision, LossUnited States
-
The University of Texas Medical Branch, GalvestonCompleted
-
Ocuphire Pharma, Inc.CompletedNight Vision Complaints | Decrease in Night Vision | Disturbance; Vision, LossUnited States
-
University of Alabama at BirminghamRecruitingLow Vision, Both EyesUnited States
-
Lawson Health Research InstituteUnknownLow Vision Aids | Low Vision, One Eye, Unspecified Eye | Low Vision BlindnessCanada
-
University of California, Los AngelesUniversity of Nebraska; Southern California College of Optometry at Marshall... and other collaboratorsRecruitingLow Vision | Low Vision AidsUnited States
-
Aristotle University Of ThessalonikiRecruitingLow Vision Digital AssistanceGreece
-
Sun Yat-sen University2nd Affilliated Hospital of Fujian Medical UniversityRecruitingArtificial Intelligence | Ophthalmology | Low Vision AidsChina
-
Pamukkale UniversityCompleted
-
Sun Yat-sen UniversityRecruitingArtificial Intelligence | Ophthalmology | Low Vision AidsChina
Clinical Trials on ICAPS Eye Vitamin and Mineral Supplement - Softgel (full strength)
-
University GhentFlemish Interuniversity Council (VLIR); Arba Minch University, EthiopiaCompletedVitamin A Deficiency | Anemia, Iron Deficiency | Cognitive Development | Helminthic InfectionEthiopia
-
Ioannis K. Triantafyllopoulos, MD,MSci,PhDCompletedOsteopenia | Postmenopausal Osteopenia
-
Penn State UniversityCalifornia Dried Plum BoardActive, not recruiting
-
Medical University of ViennaCompleted
-
Indonesia UniversityDepartment of Medical Research, Lower MyanmarCompleted
-
Eli Lilly and CompanyCompletedOsteoporosis, PostmenopausalUnited States, Belgium, Canada, Austria, Czech Republic, Denmark, Netherlands, New Zealand, Sweden, Finland, Argentina, Australia, Hungary, Israel, Italy, Norway, Poland
-
Medical University of ViennaCompletedRetina | Regional Blood Flow | Endotoxin, Escherichia ColiAustria
-
Augusta UniversityCompletedObesity | Overweight | Vitamin D DeficiencyUnited States
-
University Health Network, TorontoCrohn's and Colitis FoundationTerminatedCrohn's Disease | Ulcerative Colitis | Mild or Moderate AnaemiaCanada
-
Arizona State UniversityAutism Research Institute; Legacy FoundationCompleted